Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma.
Loeuillard E, Li B, Stumpf HE, Yang J, Willhite J, Tomlinson JL, Wang J, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI.
Loeuillard E, et al. Among authors: smoot rl.
bioRxiv [Preprint]. 2023 Jul 11:2023.05.24.541931. doi: 10.1101/2023.05.24.541931.
bioRxiv. 2023.
PMID: 37293061
Free PMC article.
Updated.
Preprint.